The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Abcam Expects Double Digit Revenue Growth In First Half

Tue, 08th Jan 2019 08:33

LONDON (Alliance News) - Life sciences research tools supplier Abcam PLC said Tuesday it expects 11% growth in revenue in the first half and remains on track to deliver its full-year financial targets.

Abcam said the performance is a result of a "multi-year invest-to-grow strategy".

The biotech company continues to gain a market share in global research, particularly in recombinant antibodies, immunoassays and has expanded into China.

"Global demand is strong for precision life science tools and Abcam has once again gained market share in these growing markets. Our business is on track to achieve double-digit growth for the year," said Chief Executive Officer Alan Hirzel.

Abcam hit its 20% revenue growth target for the first half from recombinant antibodies and exceeded the target for immunoassays revenue growth, achieving 27%.

The company's catalogue revenue increased by over 11%, with custom products & licensing revenue - which represents about 6% of total revenue - increased by about 5%.

Hirzel added: "During the half we have continued to focus on improving our service for customers. We have further developed our product portfolio and we have continued to enhance our organisational capabilities to support our ambition of becoming the most influential company for life scientists, supporting research, diagnostic and therapeutic discovery."

Abcam is set to release its interim results for the six months to the end of December on March 4.

For its 2017 financial year, the company reported pretax profit of GBP69.1 million on revenue of GBP233.2 million.

Shares in Abcam were up 0.1% Tuesday morning at 1,149.00 pence each.

More News
27 Oct 2021 08:48

Abcam completes earnings-accretive BioVision acquisition

(Sharecast News) - Science research tools company Abcam announced on Wednesday that it has completed its acquisition of BioVision from Boai NKY Medical Holdings, for total consideration of $340m.

Read more
30 Sep 2021 09:35

LONDON BROKER RATINGS: Keppler Cheuvreux raises Pearson to Hold

LONDON BROKER RATINGS: Keppler Cheuvreux raises Pearson to Hold

Read more
15 Sep 2021 09:39

LONDON BROKER RATINGS: HSBC lifts Compass to Buy; RBC cuts JTC

LONDON BROKER RATINGS: HSBC lifts Compass to Buy; RBC cuts JTC

Read more
13 Sep 2021 13:01

IN BRIEF: Abcam profit grows as lab activity and demand recover

IN BRIEF: Abcam profit grows as lab activity and demand recover

Read more
6 Sep 2021 15:58

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Sep 2021 16:22

PRESS: IP Group's Oxford Nanopore set for London float soon - Reuters

PRESS: IP Group's Oxford Nanopore set for London float soon - Reuters

Read more
13 Aug 2021 14:45

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out

Read more
2 Aug 2021 09:48

Abcam to buy BioVision for $340m

(Sharecast News) - Abcam said on Monday that it has agreed to buy California-based BioVision for $340m.

Read more
2 Aug 2021 08:55

Abcam to acquire Boai NKY subsidiary BioVision for USD340 million

Abcam to acquire Boai NKY subsidiary BioVision for USD340 million

Read more
2 Aug 2021 07:43

LONDON MARKET PRE-OPEN: Meggitt agrees to GBP6.3 billion takeover

LONDON MARKET PRE-OPEN: Meggitt agrees to GBP6.3 billion takeover

Read more
1 Jul 2021 13:17

Abcam trades in line with expectations as lab product demand limited

Abcam trades in line with expectations as lab product demand limited

Read more
24 Jun 2021 16:07

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
24 Jun 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
23 Jun 2021 09:31

BROKER RATINGS: HSBC cuts Burberry; Deutsche raises Travis Perkins

BROKER RATINGS: HSBC cuts Burberry; Deutsche raises Travis Perkins

Read more
2 Jun 2021 10:54

Abcam confirms financial year-end date change to December 31

Abcam confirms financial year-end date change to December 31

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.